Næste

Automatisk afspilning

Dr. May on Olaratumab Activity in Pediatric Bone and Soft Tissue Sarcoma

4 Visninger • 07/18/23
Del
Indlejre
administrator
administrator
Abonnenter
0

Caitlin May, PhD, postdoctoral research fellowship at Eli Lilly and Company, discusses olaratumab's (Lartruvo) demonstrating anti-tumor activity in models of pediatric bone and soft-tissue sarcoma.

Vis mere
0 Kommentarer sort Sorter efter
Facebook kommentarer

Næste

Automatisk afspilning